Early Holocene Socio-Ecological Dynamics in the Iberian Peninsula: A Network Approach

2020 ◽  
pp. 287-290
Author(s):  
Sergi Lozano ◽  
Luce Prignano ◽  
Magdalena Gómez-Puche ◽  
Javier Fernández-López de Pablo
Keyword(s):  
Iberian Peninsula ◽  
Early Holocene ◽  
Network Approach ◽  
Ecological Dynamics

Lateglacial to Early Holocene recursive aridity events in the SE Mediterranean Iberian Peninsula: The Salines playa lake case study

2016 ◽  
Vol 403 ◽  
pp. 187-200 ◽  
Author(s):  
Francesc Burjachs ◽  
Samantha E. Jones ◽  
Santiago Giralt ◽  
Javier Fernández-López de Pablo
Keyword(s):  
Iberian Peninsula ◽  
Early Holocene ◽  
Playa Lake

Early Holocene humidity patterns in the Iberian Peninsula reconstructed from lake, pollen and speleothem records

2018 ◽  
Vol 181 ◽  
pp. 1-18 ◽  
Author(s):  
Mario Morellón ◽  
Josu Aranbarri ◽  
Ana Moreno ◽  
Penélope González-Sampériz ◽  
Blas L. Valero-Garcés
Keyword(s):  
Iberian Peninsula ◽  
Early Holocene

Younger Dryas – early Holocene transition in the south‐eastern Iberian Peninsula: insights from land snail shell middens

2013 ◽  
Vol 28 (8) ◽  
pp. 777-788 ◽  
Author(s):  
YURENA YANES ◽  
MAGDALENA GÓMEZ‐PUCHE ◽  
MARCO A. ESQUEMBRE‐BEBIA ◽  
JAVIER FERNÁNDEZ‐LÓPEZ‐DE‐PABLO
Keyword(s):  
Iberian Peninsula ◽  
Younger Dryas ◽  
Land Snail ◽  
Early Holocene ◽  
The South ◽  
Shell Middens ◽  
Snail Shell ◽  
South Eastern

The Collaborative Network Approach: a model for advancing patient-centric research for Castleman disease and other rare diseases

2019 ◽  
Vol 3 (1) ◽  
pp. 97-105
Author(s):  
Mary Zuccato ◽  
Dustin Shilling ◽  
David C. Fajgenbaum
Keyword(s):  
Rare Diseases ◽  
Treatment Options ◽  
Castleman Disease ◽  
High Impact ◽  
Collaborative Network ◽  
Network Approach ◽  
Grant Applications ◽  
Research Questions ◽  
Novel Strategy ◽  
Patient Centric

Abstract There are ∼7000 rare diseases affecting 30 000 000 individuals in the U.S.A. 95% of these rare diseases do not have a single Food and Drug Administration-approved therapy. Relatively, limited progress has been made to develop new or repurpose existing therapies for these disorders, in part because traditional funding models are not as effective when applied to rare diseases. Due to the suboptimal research infrastructure and treatment options for Castleman disease, the Castleman Disease Collaborative Network (CDCN), founded in 2012, spearheaded a novel strategy for advancing biomedical research, the ‘Collaborative Network Approach’. At its heart, the Collaborative Network Approach leverages and integrates the entire community of stakeholders — patients, physicians and researchers — to identify and prioritize high-impact research questions. It then recruits the most qualified researchers to conduct these studies. In parallel, patients are empowered to fight back by supporting research through fundraising and providing their biospecimens and clinical data. This approach democratizes research, allowing the entire community to identify the most clinically relevant and pressing questions; any idea can be translated into a study rather than limiting research to the ideas proposed by researchers in grant applications. Preliminary results from the CDCN and other organizations that have followed its Collaborative Network Approach suggest that this model is generalizable across rare diseases.

The psychopharmacology of latent inhibition: A neural network approach

1997 ◽  
Author(s):  
Nestor A. Schmajuk ◽  
Catalin V. Buhusi ◽  
Jeffrey A. Gray
Keyword(s):  
Neural Network ◽  
Latent Inhibition ◽  
Network Approach ◽  
Neural Network Approach

Don’t blame the model: Reconsidering the network approach to psychopathology.

2018 ◽  
Vol 125 (4) ◽  
pp. 606-615 ◽  
Author(s):  
Laura F. Bringmann ◽  
Markus I. Eronen
Keyword(s):  
Network Approach
Sign in / Sign up

Export Citation Format

Share Document